Kenquist Nominees Pty Limited v Campbell (No 3)

Kenquist Nominees Pty Limited v Campbell (No 3) concerns an application for discovery of documents and the disputes surrounding claims of privilege. The matter was heard in the Federal Court of Australia, where the applicant sought to obtain documents from various respondents, including QRxPharma Limited, which had not been directly sued in the principal proceeding but whose legal interests could potentially be affected by the outcome. The case involved the interpretation and application of the Court's Central Practice Note on National Court Framework and Case Management and the Federal Court Rules concerning discovery of documents.

The primary legal issue before the court was whether the applicant had properly followed the agreed protocol for discovery, as expected by the Court’s Central Practice Note, and whether the respondents were required to provide a list of documents under the Federal Court Rules without an order, as stated in Rule 20.12. The court also had to determine the appropriate form and content of the lists of documents to be given, considering the claims of privilege made by the respondents.

In addressing these issues, the court highlighted the importance of cooperation between parties and their lawyers in minimising the burden of discovery and adhering to the overarching purpose of the Court's civil practice and procedure. The court noted that parties should discuss discovery issues and, if possible, agree on a protocol that could obviate the need for strict compliance with the Federal Court Rules. The court emphasised that discovery should facilitate the just resolution of the proceeding as quickly, inexpensively and efficiently as possible. The court concluded that the applicant had not adequately followed the agreed protocol for discovery and that the claims of privilege needed further substantiation.

The court dismissed the applicant’s claims for relief in paragraphs 1 to 5 of the amended interlocutory application and ordered the applicant to pay the costs of the respondents and QRxPharma Limited for the claims referred to in the order. The dismissal was based on the failure to follow the agreed protocol and the inadequacy of the claims of privilege. The court's decision underscored the necessity for parties to approach discovery with the goal of efficient and cost-effective resolution of disputes.